- Bupa Platinum consultant
- Fee assured
- Awaiting verification
- Open Referral network
Offers
- Face-to-face consultations
- Video and telephone consultations
About me
Dr Peter Dickinson graduated from the University of Nottingham Medical School in 2004 and undertook his specialist Clinical Oncology Training in Nottingham, followed by a radiotherapy research fellowship at the Christie Hospital in Manchester. He was appointed consultant at Leeds Teaching Hospitals Trust in 2013. He is Radiotherapy Clinical Lead at Leeds Teaching Hospitals.
Dr Dickinson specialises in the treatment of lung cancer and the use of stereotactic radiotherapy to treat metastatic cancer. He is a key member of the Stereotactic Ablative Radiotherapy (SABR) team at Leeds Teaching Hospital Trust and is lead clinician for the oligometastatic radiotherapy programme, which focuses upon the treatment of early-stage metastasis.
He has an active interest in clinical research and has been the Principal or Co-Investigator for numerous national and international clinical trials investigating the use of new radiotherapy techniques as well as systemic therapy. He sits on the Trial Management Group for a national radiotherapy study. Dr Dickinson has also published a number of papers on radiotherapy, chemotherapy and basic science
Areas of interest
Lung cancer; Stereotactic radiotherapy for oligometastatic disease
Medical secretaries
- Jayne Bell
- NOVA Healthcare Level 4 Bexley Wing St James's University Hospital Beckett Street Leeds LS9 7TF
- 0113 206 8699
- 0113 206 7438
Information for healthcare professionals (Bupa patients only, last 12 months)
-
X6950
Clinical supervision of the planning of stereotactic radiosurgery e.g. SRT/SBRT and Gamma Knife - (1-5)
-
X0007
Clinical supervision of external beam radiotherapy, up to and including 15 fractions or part thereof - (1-5)
-
A1070
Stereotactic radiotherapy (SRT), first/sole session using Cyberknife or similar SRT technology - (1-5)